Clincosm LogoSign in Get a demo

Evaluation of the Effect of an APP in Improving Treatment Adherence in Hypertensive Patients in Hypertension Ambulatory

Sponsor
Instituto de Cardiologia do Rio Grande do Sul (Other)
Overall Status
Unknown status
CT.gov ID
NCT04475367
Collaborator
(none)
44
Enrollment
2
Arms
17.7
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Brief Summary: Through the App, the user will have the opportunity to connect directly with the health professional, clarify doubts and manage the treatment of their hypertension.

Condition or Disease Intervention/Treatment Phase
  • Other: App hypercross group
  • Other: without App hypercross group
 N/A

Detailed Description

To evaluate treatment adherence and blood pressure reduction, through the HiperCross App, between two groups of hypertensive patients in a Hypertension Public Ambulatory in Porto Alegre.

The investigators hope to identify better adherence to treatment, as well as a significant reduction in blood pressure, all of these results will be better evaluated using the HiperCross application.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The participants will be randomized into 2 intervention groupsThe participants will be randomized into 2 intervention groups
Masking:
Single (Outcomes Assessor)
Masking Description:
blind research assistant
Primary Purpose:
Screening
Official Title:
Evaluation of the Effect of an APP in Improving Treatment Adherence in Hypertensive Patients in Hypertension Ambulatory
Anticipated Study Start Date :
Jul 10, 2020
Anticipated Primary Completion Date :
Dec 20, 2021
Anticipated Study Completion Date :
Dec 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: hypertensive patients using HyperCrossApp

Interdisciplinary health care + HyperCross App

Other: App hypercross group
hypertensive patients using HyperCrossApp
Active Comparator: hypertensive patients without using HyperCrossApp

Interdisciplinary health care

Other: without App hypercross group
Interdisciplinary health care

Outcome Measures

Primary Outcome Measures

  1. Blood pressure value [15 minutes]

    systolic Blood pressure and dyastolic Blood pressure

Secondary Outcome Measures

  1. Morisky scale [15 minutes]

    Medication adherence. The Morisky scale condition and medication specific assessment: 1) measures the level of adherence an medication, 2) measures the severity of Major Depressive Disorder, a determinant of non-adherence 3) identifies why the patient is not taking their medication, 4) determines the risk between non-adherence to BP measures of disease control. 0-1 = Low motivation; 2-3 = High motivation / 0-1 = Low knowledge; 2-3 = High knowledge

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • hypertensive patients admitted to the hypertension clinic at Instituto de Cardiologia

  • older 18 years

Exclusion Criteria:
  • Patients without a mobile phone compatible with the App

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Instituto de Cardiologia do Rio Grande do Sul

Investigators

  • Study Director: Bruna Eibel, PhD, Post Graduation professor - Cardiology Foundation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ana Paula Reis, Nurse Specialist, Instituto de Cardiologia do Rio Grande do Sul
ClinicalTrials.gov Identifier:
NCT04475367
Other Study ID Numbers:
  • 5701-19
First Posted:
Jul 17, 2020
Last Update Posted:
Jul 21, 2020
Last Verified:
Jul 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ana Paula Reis, Nurse Specialist, Instituto de Cardiologia do Rio Grande do Sul
software
hypertension
technology
Additional relevant MeSH terms:
Hypertension

Study Results

No Results Posted as of Jul 21, 2020